Stage IIIA Colorectal Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Panitumumab (DB01269)

IndicationStatusPhase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03992456Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerTreatment